OFFER DEADLINE EXTENDED TO END OF FEBRUARY!
This Offer is available to patients ages 18 and over with a valid prescription for Afrezza® (insulin human) Inhalation Powder. Must be a U.S. resident, with a valid U.S. shipping address to qualify.
By participating in this Offer, you acknowledge and represent that you will not seek or accept reimbursement for purchases made under this program from any insurance program or third party reimbursement provider. This Offer is void where prohibited by law. MannKind Corporation reserves the right to rescind, revoke or amend this program without notice.
For the first 1,000 registrants under this initial Direct Purchase Program Offer, prices are guaranteed for 12 months from time of first fill. Currently, eligible, enrolled patients pay:
For additional important information regarding Afrezza, please see full Prescribing Information, including Boxed WARNING, Medication Guide, and Instructions for Use.